Sign In

Login

Password

Forgot Password ? Sign Up

Tumor marker (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Tumor marker" in English language version.

refsWebsite
Global rank English rank
28nih.gov
4th place
4th place
17doi.org
2nd place
2nd place
2worldcat.org
5th place
5th place
1genome.gov
9,308th place
8,899th place
1books.google.com
3rd place
3rd place
1inist.fr
2,854th place
3,669th place
1iiarjournals.org
low place
low place

books.google.com

doi.org

genome.gov

iiarjournals.org

ar.iiarjournals.org

inist.fr

pascal-francis.inist.fr

  • Lüftner, D.; Mesterharm, J.; Akrivakis, C.; Geppert, R.; Petrides, P. E.; Wernecke, K. D.; Possinger, K. (2000). "Tumor type M2 pyruvate kinase expression in advanced breast cancer". Anticancer Research. 20 (6D): 5077–5082. PMID 11326672. INIST 1059012.

nih.gov

pubmed.ncbi.nlm.nih.gov

  • Faria, S. C.; Sagebiel, T.; Patnana, M.; Cox, V.; Viswanathan, C.; Lall, C.; Qayyum, A.; Bhosale, P. R. (April 2019). "Tumor markers: myths and facts unfolded". Abdominal Radiology. 44 (4): 1575–1600. doi:10.1007/s00261-018-1845-0. PMID 30498924.
  • Nagpal, Madhav; Singh, Shreya; Singh, Pranshu; Chauhan, Pallavi; Zaidi, Meesam Abbas (2016). "Tumor markers: A diagnostic tool". National Journal of Maxillofacial Surgery. 7 (1): 17–20. doi:10.4103/0975-5950.196135. PMC 5242068. PMID 28163473.
  • Sharma, S. (2009). "Tumor markers in clinical practice: General principles and guidelines". Indian Journal of Medical and Paediatric Oncology. 30 (1): 1–8. doi:10.4103/0971-5851.56328. PMC 2902207. PMID 20668599.
  • Hayes, D. F.; Bast, R. C.; Desch, C. E.; Fritsche, H.; Kemeny, N. E.; Jessup, J. M.; Locker, G. Y.; Macdonald, J. S.; Mennel, R. G.; Norton, L.; Ravdin, P.; Taube, S.; Winn, R. J. (16 October 1996). "Tumor Marker Utility Grading System: a Framework to Evaluate Clinical Utility of Tumor Markers". JNCI Journal of the National Cancer Institute. 88 (20): 1456–1466. doi:10.1093/jnci/88.20.1456. PMID 8841020.
  • Koepke, John A. (15 March 1992). "Molecular marker test standardization". Cancer. 69 (S6): 1578–1581. doi:10.1002/1097-0142(19920315)69:6+<1578::AID-CNCR2820691312>3.0.CO;2-K. PMID 1540898.
  • Keshaviah, A; Dellapasqua, S; Rotmensz, N; Lindtner, J; Crivellari, D; Collins, J; Colleoni, M; Thurlimann, B; et al. (2006). "CA15-3 and alkaline phosphatase as predictors for breast cancer recurrence: A combined analysis of seven International Breast Cancer Study Group trials". Annals of Oncology. 18 (4): 701–8. doi:10.1093/annonc/mdl492. PMID 17237474.
  • Gion, M; Mione, R; Leon, A.E; Lüftner, D; Molina, R; Possinger, K; Robertson, J.F (February 2001). "CA27.29". European Journal of Cancer. 37 (3): 355–363. doi:10.1016/s0959-8049(00)00396-8. PMID 11239757.
  • Lee, Tsinrong; Teng, Thomas Zheng Jie; Shelat, Vishal G (27 December 2020). "Carbohydrate antigen 19-9 — tumor marker: Past, present, and future". World Journal of Gastrointestinal Surgery. 12 (12): 468–490. doi:10.4240/wjgs.v12.i12.468. PMC 7769746. PMID 33437400.
  • Osman, N.; O'Leary, N.; Mulcahy, E.; Barrett, N.; Wallis, F.; Hickey, K.; Gupta, R. (September 2008). "Correlation of serum CA125 with stage, grade and survival of patients with epithelial ovarian cancer at a single centre". Irish Medical Journal. 101 (8): 245–247. OCLC 270998384. PMID 18990955.
  • Bast, R.C.; Xu, F.-J.; Yu, Y.-H.; Barnhill, S.; Zhang, Z.; Mills, G.B. (October 1998). "CA 125: The past and the Future". The International Journal of Biological Markers. 13 (4): 179–187. doi:10.1177/172460089801300402. PMID 10228898.
  • Kudo, Takumi; Miyauchi, Akira; Ito, Yasuhiro; Yabuta, Tomonori; Inoue, Hiroyuki; Higashiyama, Takuya; Tomoda, Chisato; Hirokawa, Mitsuhide; Amino, Nobuyuki (2011). "Serum calcitonin levels with calcium loading tests before and after total thyroidectomy in patients with thyroid diseases other than medullary thyroid carcinoma". Endocrine Journal. 58 (3): 217–221. doi:10.1507/endocrj.k10e-359. PMID 21358115.
  • Ke, Zunfu; Lai, Yuanhua; Ma, Xudong; Lil, Shuhua; Huang, Wenhua (February 2014). "Diagnosis of bladder cancer from the voided urine specimens using multi-target fluorescence in situ hybridization". Oncology Letters. 7 (2): 325–330. doi:10.3892/ol.2013.1744. PMC 3881196. PMID 24396440.
  • Hallek, M.; Wanders, L.; Strohmeyer, S.; Emmerich, B. (July 1992). "Thymidine kinase: a tumor marker with prognostic value for non-Hodgkin's lymphoma and a broad range of potential clinical applications". Annals of Hematology. 65 (1): 1–5. doi:10.1007/BF01715117. PMID 1643153.
  • Haug, U; Rothenbacher, D; Wente, M N; Seiler, C M; Stegmaier, C; Brenner, H (2007). "Tumour M2-PK as a stool marker for colorectal cancer: Comparative analysis in a large sample of unselected older adults vs colorectal cancer patients". British Journal of Cancer. 96 (9): 1329–34. doi:10.1038/sj.bjc.6603712. PMC 2360192. PMID 17406361.
  • Lüftner, D.; Mesterharm, J.; Akrivakis, C.; Geppert, R.; Petrides, P. E.; Wernecke, K. D.; Possinger, K. (2000). "Tumor type M2 pyruvate kinase expression in advanced breast cancer". Anticancer Research. 20 (6D): 5077–5082. PMID 11326672. INIST 1059012.
  • Benesch, Carina; Schneider, Christine; Voelker, Hans-Ullrich; Kapp, Michaela; Caffier, Hans; Krockenberger, Mathias; Dietl, Johannes; Kammerer, Ulrike; Schmidt, Melanie (May 2010). "The Clinicopathological and Prognostic Relevance of Pyruvate Kinase M2 and pAkt Expression in Breast Cancer". Anticancer Research. 30 (5): 1689–1694. PMID 20592362.
  • Wechsel, HW; Petri, E; Bichler, KH; Feil, G (1999). "Marker for renal cell carcinoma (RCC): The dimeric form of pyruvate kinase type M2 (Tu M2-PK)". Anticancer Research. 19 (4A): 2583–90. PMID 10470199.
  • Schneider, J.; Peltri, G.; Bitterlich, N.; Philipp, M.; Velcovsky, H.G.; Morr, H.; Katz, N.; Eigenbrodt, E. (February 2003). "Fuzzy logic-based tumor marker profiles improved sensitivity of the detection of progression in small-cell lung cancer patients". Clinical and Experimental Medicine. 2 (4): 185–191. doi:10.1007/s102380300005. PMID 12624710.
  • Оремек, Г; Лукшайте, Р; Sapoutzis, Н; Зиолковски, П (2007). "Значение маркера опухоли TU M2-PK в диагностике рака легких" [The significance of TU M2-PK tumor marker for lung cancer diagnostics]. Клиническая медицина [Klinicheskaia Meditsina] (in Russian). 85 (7): 56–58. PMID 17882813.
  • Hardt, PD; Ngoumou, BK; Rupp, J; Schnell-Kretschmer, H; Kloer, HU (2000). "Tumor M2-pyruvate kinase: A promising tumor marker in the diagnosis of gastro-intestinal cancer". Anticancer Research. 20 (6D): 4965–8. PMID 11326648.
  • Kumar, Yogesh; Tapuria, Niteen; Kirmani, Naveed; Davidson, Brian R. (2007). "Tumour M2-pyruvate kinase: A gastrointestinal cancer marker". European Journal of Gastroenterology & Hepatology. 19 (3): 265–276. doi:10.1097/MEG.0b013e3280102f78. PMID 17301655.
  • Kaura, B; Bagga, R; Patel, FD (2004). "Evaluation of the Pyruvate Kinase isoenzyme tumor (Tu M2-PK) as a tumor marker for cervical carcinoma". The Journal of Obstetrics and Gynaecology Research. 30 (3): 193–6. doi:10.1111/j.1447-0756.2004.00187.x. PMID 15210041.
  • Ahmed, A. S.; Dew, T.; Lawton, F. G.; Papadopoulos, A. J.; Devaja, O.; Raju, K. S.; Sherwood, R. A. (2007). "M2-PK as a novel marker in ovarian cancer. A prospective cohort study". European Journal of Gynaecological Oncology. 28 (2): 83–88. OCLC 124560760. PMID 17479666.

ncbi.nlm.nih.gov

worldcat.org

search.worldcat.org

  • Osman, N.; O'Leary, N.; Mulcahy, E.; Barrett, N.; Wallis, F.; Hickey, K.; Gupta, R. (September 2008). "Correlation of serum CA125 with stage, grade and survival of patients with epithelial ovarian cancer at a single centre". Irish Medical Journal. 101 (8): 245–247. OCLC 270998384. PMID 18990955.
  • Ahmed, A. S.; Dew, T.; Lawton, F. G.; Papadopoulos, A. J.; Devaja, O.; Raju, K. S.; Sherwood, R. A. (2007). "M2-PK as a novel marker in ovarian cancer. A prospective cohort study". European Journal of Gynaecological Oncology. 28 (2): 83–88. OCLC 124560760. PMID 17479666.